Halozyme Therapeutic (HALO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select FieldsSymbol | HALO | AMGN | VRTX | REGN | GSK |
Company | Halozyme Therapeutic | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Gsk Plc ADR |
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
Open | 44.85 | 314.41 | 444.72 | 980.42 | 45.06 |
High | 45.07 | 315.81 | 447.58 | 985.00 | 45.15 |
Low | 44.30 | 312.92 | 442.99 | 978.21 | 44.95 |
Last | 44.57 | 313.74 | 446.77 | 979.71 | 45.12 |
Change | -0.14 | +1.27 | +1.56 | -2.58 | +0.14 |
% Change | -0.31% | +0.41% | +0.35% | -0.26% | +0.31% |
Volume | 197,816 | 459,762 | 199,062 | 93,117 | 576,091 |
20-Day Average Volume | 964,336 | 2,823,998 | 1,061,756 | 442,520 | 3,327,232 |
Previous Close | 44.71 | 312.47 | 445.21 | 982.29 | 44.98 |
Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
Has Options | Yes | Yes | Yes | Yes | Yes |
Technicals | |||||
20-Day Moving Average | 41.50 | 295.67 | 414.76 | 943.37 | 43.48 |
20-Day Raw Stochastic | 79.62% | 84.72% | 98.60% | 93.99% | 84.23% |
20-Day Relative Strength | 64.79% | 64.37% | 72.71% | 61.03% | 66.52% |
Weighted Alpha | +35.16 | +42.01 | +36.52 | +34.50 | +35.07 |
Today's Opinion | 88% Buy | 72% Buy | 72% Buy | 100% Buy | 100% Buy |
Previous Opinion | 88% Buy | 72% Buy | 72% Buy | 72% Buy | 100% Buy |
Last Month's Opinion | 24% Buy | 56% Sell | 8% Buy | 24% Buy | 24% Buy |
Performance | |||||
5-Days | |||||
%Chg | +2.02% since 05/13/24 | +1.77% since 05/13/24 | +3.92% since 05/13/24 | +0.53% since 05/13/24 | -0.19% since 05/13/24 |
Low | 43.55 on 05/14/24 | 307.47 on 05/14/24 | 422.44 on 05/14/24 | 966.00 on 05/17/24 | 44.74 on 05/17/24 |
High | 46.16 on 05/16/24 | 321.44 on 05/15/24 | 447.58 on 05/20/24 | 988.96 on 05/15/24 | 45.92 on 05/15/24 |
1-Month | |||||
%Chg | +15.14% since 04/19/24 | +16.73% since 04/19/24 | +13.32% since 04/19/24 | +9.51% since 04/19/24 | +13.42% since 04/19/24 |
Low | 37.97 on 04/30/24 | 265.72 on 04/26/24 | 391.70 on 04/30/24 | 875.22 on 04/26/24 | 39.96 on 04/22/24 |
High | 46.16 on 05/16/24 | 322.60 on 05/03/24 | 447.58 on 05/20/24 | 988.96 on 05/15/24 | 45.92 on 05/15/24 |
3-Month | |||||
%Chg | +23.58% since 02/20/24 | +10.72% since 02/20/24 | +6.22% since 02/20/24 | +3.72% since 02/20/24 | +7.29% since 02/20/24 |
Low | 36.61 on 02/21/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 39.15 on 04/18/24 |
High | 46.16 on 05/16/24 | 322.60 on 05/03/24 | 447.58 on 05/20/24 | 998.33 on 02/28/24 | 45.92 on 05/15/24 |
6-Month | |||||
%Chg | +11.20% since 11/20/23 | +18.30% since 11/20/23 | +25.21% since 11/20/23 | +22.51% since 11/20/23 | +28.41% since 11/20/23 |
Low | 33.15 on 02/05/24 | 260.52 on 11/21/23 | 346.29 on 11/28/23 | 792.57 on 11/28/23 | 35.13 on 11/22/23 |
High | 46.16 on 05/16/24 | 329.72 on 02/05/24 | 448.40 on 01/30/24 | 998.33 on 02/28/24 | 45.92 on 05/15/24 |
Key Statistics | |||||
Market Capitalization, $K | 5,690,421 | 167,619,840 | 114,887,776 | 108,234,592 | 93,218,352 |
Shares Outstanding, K | 127,274 | 536,435 | 258,053 | 110,186 | 2,072,440 |
Annual Sales | 829,250,000 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 37,725,000,000 |
Annual Net Income | 281,590,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 6,129,940,000 |
Last Quarter Sales | 195,880,000 | 7,447,000,000 | 2,690,600,000 | 3,145,000,000 | 9,337,020,000 |
Last Quarter Net Income | 76,820,000 | -113,000,000 | 1,099,600,000 | 722,000,000 | 1,326,430,000 |
60-Month Beta | 1.26 | 0.60 | 0.39 | 0.17 | 0.65 |
Per-Share Information | |||||
Most Recent Earnings | 0.79 on 05/07/24 | 3.96 on 05/02/24 | 4.76 on 05/06/24 | 9.55 on 05/02/24 | 1.09 on 05/01/24 |
Latest Earnings Date | 05/07/24 | 05/02/24 | 05/06/24 | 05/02/24 | 05/01/24 |
Most Recent Dividend | N/A | 2.250 on 05/16/24 | N/A | N/A | 0.369 on 05/16/24 |
Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 05/16/24 |
Ratios | |||||
Price/Earnings ttm | 16.04 | 16.89 | 29.26 | 26.08 | 11.11 |